YieldMax MRNA Option Income Strategy ETF

$Moderna(MRNA.US)

POST for 14/9 (Next Episode)

1️⃣ I sold MRNA at this price because the stock had rebounded strongly and I viewed that level as an opportunity to lock in gains while reducing exposure to biotech volatility and uncertainly around future vaccine revenue.

2️⃣ I did not want to add after my last purchase because the investment thesis had not materially improved, and I preferred to wait for clearer evidence of sustainable earning growth.

3️⃣ Looking a few months ahead, the outlook depends on pipeline progress, regulatory updates and commercialisation pressures may keep the stock range bound.

💊$Moderna(MRNA.US)

Breaking: We found a politician day trading a cancer treatment

$XTALPI(02228.HK) On the plane, reading some materials on Moderna, I suddenly feel that maybe Crownpeak's decision to abandon its own pipeline and focus solely on being a platform could be a mistake. This might be a potential concern and point of reflection for the market in its pricing. After all, the business model of a platform approach always lacks certainty. However, interestingly, Crownpeak's role in driving pipeline progress within the ecosystem is positive.

It really puts me in a dilemma.

I’m not sure the surge in Moderna’s price will last given the previous experience of it giving back the gains very quickly. Buy on rumour and sell on news?

An interesting opinion I read the other day when someone said the typical Singaporean "safe investment" of chasing STI etf/ 3 local banks could be riskier than one would think it is. The heavy concentration in the banking sector and lack of diversification could prove risky from time to time as the financial sector is tightly linked to interest rate cycles, property markets and non wealth products. On the flipside, the blue chip companies have been proven over time to generate decent and stable returns (including consistent dividend payouts).

In short as said many times, trust your thesis love your leader, all things will comes into flow cos the leader cannot lose more than us. We are nothing compared to their own reputation. Swings is inevitable as this is a stock market. Bottom line love your leader !💪🇺🇸🤺🎢⛳️😎❤️

$Moderna(MRNA.US) although momentum is cooling off, the setup is still in tact and holding the mighty pink line.

$Moderna(MRNA.US)

1️⃣ Exploded high after Moderna and Merck announced positive Ph3 result for their personalised mRNA melanoma cancer therapy, the first mRNA cancer treatment to achieve such a milestone. The news triggered a major short squeeze and a sharp re rating of Moderna’s future prospects.

2️⃣ I added a position cause the market narrative changed from a declining COVID company to a potential cancer treatment platform. One successful Ph3 trial can reshape future revenues expectations.

3️⃣ AI stocks depend mainly on earnings, adoption and valuation. MRNA depends on clinical, regulatory and pipeline milestones. In 2 months, I would gauge MRNA by follow through data and institutional support, not hype. 💊🩻🩺